Print Page | Sign In | Join
News & Press: People on the Move

Lions Eye Institute for Transplant & Research’s New Chairman

Wednesday, September 24, 2014   (0 Comments)
Share |

Lions Eye Institute for Transplant & Research’s New Chairman Dedicated to Fighting Blinding Eye Disease

Dr. John T. LiVecchi Appointed Chairman of Board of Directors


Tampa, Fla. (September 24, 2014) – The Lions Eye Institute for Transplant & Research (LEITR) board of directors has elected John T. LiVecchi, MD, FACS, FSEE, a board-certified ophthalmologist and fellowship-trained ocuplastic surgeon, as the chairman of its board of directors, according to a company news release. As chairman, Dr. LiVecchi will lead the board in its strategic plan to support sight-related outreach, education, treatment and research. Dr. LiVecchi was the first Physician in the 40 year history of LEITR to be elected Chairman.  His term started July 1, 2014.  He served as the Vice Chairman of The Board of Directors for the past two years and was also the inaugural Chairman of the Visionary Committee there as well.  LEITR is one of the world's largest eye banks with the only eye bank to have a state-of-the-art ocular tissue research facility onsite. LEITR provides whole globes, corneas, lenses, sclera, retinas/retinal pigment epithelium, and other tissues/cells from healthy and diseased eyes, including macular degeneration, diabetic retinopathy and glaucoma, many within 4 to 6 hours after death. An Ocular Bio-repository is currently being considered to expand our research tissue offerings along with research projects that are currently underway.

"While Dr. LiVecchi's term as chairman just began, he has been an integral part of our board for the past three years and we look forward to his leadership," Jason Woody, President and CEO of LEITR, said in the news release. Dr. LiVecchi has been voted top oculoplastic surgeon in the United States 10 years in a row by the Consumer Research Council of America and travels worldwide as a course director teaching state-of-the-art surgery. He currently is the medical director for three medical companies in the United States and sits on several other boards as an officer and a director. “At some point, every person will experience some level of vision loss,” said Dr. LiVecchi, “This organization has unique aspect in that it focuses on ocular research that may one day help in the global fight against blindness. I am honored to serve as board chair for LEITR.”

Dr. LiVecchi’s passions are science, medicine and patient care. Dr. LiVecchi received a Bachelor of Science Degree from the City University of New York at Richmond and earned his Medical Doctorate from the University of Rome. He served his internship at Long Island College Hospital in Brooklyn, New York and completed a residency in ophthalmology at the State University of New York, Downstate Medical Center and was chief resident there from 1981 to 1982. From 1982 to 1983 he was a Fellow in Oculoplastic Surgery at the Kresge Eye Institute of Wayne State University in Detroit, Michigan. Dr. LiVecchi is a Clinical Assistant Professor at the University of Central Florida College of Medicine in Orlando, Florida.


About the Lions Eye Institute for Transplant & Research (LEITR)

The Lions Eye Institute for Transplant & Research, Inc., (LEITR) is a nonprofit, charitable organization dedicated to the recovery, evaluation and distribution of eye tissue for transplantation, research and education. LEITR’s Eye Bank, located in Tampa, Fla., is the only combined eye bank and ocular research center in the world.  Since its inception, it has brought the “Gift of Sight” to more than 65,000 men, women and children worldwide. For more information, visit


Media Contact:

Angela Pottinger, Development Coordinator

(813) 289-1200 (Main)

About BioFlorida

BioFlorida represents nearly 6,000 establishments and research organizations in the biopharmaceutical, medical technology and bioagriculture sectors that collectively employ nearly 83,000 Floridians.


Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.


Email us for a regional Chapter sponsorship.